Navigation Links
KaloBios to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Date:9/23/2013

SOUTH SAN FRANCISCO, Calif., Sept. 23, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will present at the BioCentury NewsMakers in the Biotech Industry Conference on September 27 at the Millennium Broadway Hotel & Conference Center in New York City. KaloBios President and Chief Executive Officer, David W. Pritchard, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.

(Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO)

Company Presentation:
When: Friday, September 27, 2013, 11:00 AM EDT
Where: Millennium Broadway Hotel & Conference Center, New York City, NY

Webcast:
To access the live and archived audio webcast of the NewsMakers presentation, please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: http://www.visualwebcaster.com/event.asp?id=95820.

A replay of the webcast will be available one hour after the conclusion of the live event. 

About KaloBios
KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat severe medical conditions with a primary clinical focus on respiratory diseases and cancer.  For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Contact:

Jeffrey H. Cooper
Chief Financial Officer
KaloBio
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. KaloBios Announces Retirement Of Chief Financial Officer
2. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
3. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
4. KaloBios Announces Fiscal Year 2012 Financial Results
5. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
6. AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas
7. PTC Therapeutics to Present at European Pediatric Neurology Society Congress
8. MEI Pharma to Present at BioCenturys NewsMakers in the Biotech Industry Conference
9. RXi Pharmaceuticals to Present at the 12th Annual BIO Investor Forum
10. Bone Biologics Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. San Francisco Business Times Presents: Richmond! Your Home Front for Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... group leader Yung-Eun Sung has announced that they ... nitrogen-doped graphenes which can be applied as high ... Yung-Eun Sung is both a group leader at ... Basic Science* (IBS) and a professor at the ... significance with regards to the development of relative ...
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Cell Culture Market 2014-2018" report to their offering.  ... Cell culture is the in vitro growth of plant ... cell studies, and biopharmaceutical production. Cell culture is a ... culture instruments and cell culture consumables are necessary for ...
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
(Date:7/24/2014)... WIRB-Copernicus Group ® ("WCG")™, the ... services for clinical research, announced today that it ... Richmond, VA -based Alliance Engineering, ... consulting firm in the United States ... – WCG Biosafety™ – will be able to ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... the Beijing Genomics Institute), the largest genomics organization in ... of Sciences, together published the whole sequence variation map ... Genome Biology on July 6th, 2011 ( http://genomebiology.com/2011/12/7/R63 ... biomedical research. Rhesus macaque, also called the Rhesus ...
... 2011 America,s #1 rated morning news program, The ... a blood test that measures cellular aging.  The segment entitled ... Test as a tool for those interested in monitoring their ... Test measures a person,s biological age in comparison to their ...
... RIDGEFIELD, Conn., July 21, 2011 Boehringer Ingelheim ... etexilate mesylate) capsules has been added to hospital formularies at ... as ranked by U.S. News & World Report,s ... approved by the U.S. Food and Drug Administration (FDA) to ...
Cached Biology Technology:Whole sequence variation map reveals insight into evolutionary studies of rhesus macaque 2SpectraCell's Telomere Testing Goes Mainstream 2SpectraCell's Telomere Testing Goes Mainstream 3Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals 2Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals 3Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals 4Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals 5Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals 6
(Date:7/24/2014)... effects on different species of fish, according to ... and Exeter which tested fish anti-predator behaviour. ... seagull predator model when exposed to additional noise, ... , Lead author Dr Irene Voellmy of ... in many aquatic environments have increased substantially during ...
(Date:7/24/2014)... ply silent freeways, solar panels blanket rooftops and power ... howling winds and from the blazing desert sun. , ... and economically feasible to convert California,s all-purpose energy infrastructure ... Energy , the plan shows the way to ... that could create tens of thousands of jobs and ...
(Date:7/24/2014)... 24, 2014 Some sticky research out of York ... a certain species of toxic grass fungus: moose saliva ... Biology Letters , "Ungulate saliva inhibits a grassendophyte ... to red fescue grass (which hosts a fungus called ... slower fungus growth and less toxicity. , "Plants have ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4Moose drool inhibits growth of toxic fungus: York U research 2
... Meteorological Institute in Helsinki, Finland, will host the first ... Cloud Climate and Air Quality Interactions, EUCAARI, headed by ... purpose of EUCAARI is to significantly improve current knowledge ... on climate and air quality. The first year of ...
... and Profit Growth, WALL, N.J., Nov. 14 ... leader in wireless public safety and,finger-based biometric identification ... quarter ended September 30, 2007. Total revenue ... 30, 2007 was $2.2 million representing a 27% ...
... that males evolve more quickly than females has been ... majesty of a peacocks tail feather in comparison with ... species, males apparently ramp up flashier features and more ... best mates, a concept known as sexual selection. ...
Cached Biology News:Worldwide atmospheric measurements will determine the role of atmospheric fine particles 2BIO-key Reports Third Quarter 2007 Results 2BIO-key Reports Third Quarter 2007 Results 3BIO-key Reports Third Quarter 2007 Results 4BIO-key Reports Third Quarter 2007 Results 5Simple reason helps males evolve more quickly 2Simple reason helps males evolve more quickly 3
Agarose Gel Loading Dye Mixture 6X...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Biology Products: